About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Chicago | 383 Studies

Clinical Trials Prostate CancerChicago

Prostate Cancer Clinical Trials in Chicago

Find 383 clinical trials for prostate cancer near Chicago, Illinois. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 261-280 of 383 trials

Active not recruitingA Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate cancer.NCT01946204·Birmingham, Alabama and 378 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingTrial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate CancerThis study evaluates the efficacy, anti-tumor effect, and immunogenicity of neoadjuvant enoblituzumab given before radical prostatectomy.NCT06014255·Chicago, Illinois and 4 others

CompletedThe Effects of Lycopene on High Risk Prostatic TissueThe purpose of this research study is to compare the effects of a lycopene supplement made from tomatoes to a placebo (a capsule with no active ingredients) in men who have…NCT01443026·Chicago, Illinois and 1 other

CompletedEribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyThis phase II trial is studying how well eribulin mesylate (E7389; Halichondrin B Analog) works in treating patients with metastatic prostate cancer that did not respond to…NCT00337077·Scottsdale, Arizona and 146 others

TerminatedA Study of FT-7051 in Men With MCRPCThis is a Phase 1, open-label study that will evaluate the safety and tolerability of FT-7051 and determine the recommended Phase 2 dose (RP2D) as well as pharmacokinetics (PK)…NCT04575766·Scottsdale, Arizona and 7 others

RecruitingRuxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate CancerThis phase I/II tests the safety, side effects and best dose of ruxolitinib in combination with enzalutamide and how well it works in treating patients with prostate cancer that…NCT06616155·Chicago, Illinois and 2 others

CompletedIncreasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation TherapyThis trial studies how well increasing the dose of survivorship care planning improves care and outcomes in prostate cancer survivors receiving radiation therapy and androgen…NCT03860961·Kingman, Arizona and 78 others

RecruitingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsThis phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from…NCT03866382·Birmingham, Alabama and 580 others

CompletedThe "PC-LIGHT" StudyFatigue due to cancer and its treatment (for example, radiation therapy) can interfere with quality of life and can linger long after treatment has ended, yet research examining…NCT03419585·Chicago, Illinois

CompletedHormone Therapy in Treating Patients With Prostate CancerRATIONALE: Male hormones can stimulate the growth of prostate cancer cells.NCT00003323·Birmingham, Alabama and 42 others

RecruitingTesting Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerThis phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45…NCT05946213·Birmingham, Alabama and 435 others

Active not recruitingTesting the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE TrialThis phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery.NCT04134260·Phoenix, Arizona and 349 others

CompletedPhase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate CancerThe purpose of this study is to learn if men with metastatic prostate cancer and rising Prostate Specific Antigen (PSA), who have been surgically castrated or are undergoing…NCT00385580·Los Angeles, California and 10 others

CompletedA Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate CancerThe purpose of this study is to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall survival in men with few or no symptoms from…NCT01322490·Anchorage, Alaska and 219 others

CompletedMEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate CancerThe primary objectives of this study are: 1.NCT00072930·Hoover, Alabama and 56 others

Active not recruitingMedtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)This study will evaluate the safety and performance of the Medtronic Hugo™ RAS System when used for urologic RAS procedures.NCT05696444·Duarte, California and 5 others

Active not recruitingFeasibility of Hormones and Radiation for Intermediate or High Risk Prostate CancerThe purpose of this study is see if quality of life is improved in patients receiving oral hormone therapy compared to standard of care.NCT01342367·Chicago, Illinois

Active not recruitingAndrogen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens.NCT01368588·Mobile, Alabama and 477 others

RecruitingPlasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate CancerThe aim of the present study is to investigate a plasma exosome RNA signature to diagnose clinically significant prostate cancer.NCT07492927·Chicago, Illinois and 9 others

RecruitingMRI Risk Maps for Prostate Cancer Diagnosis Using Targeted BiopsyDoctors leading this study hope to learn about a software that researchers at the University of Chicago have developed to help analyze radiographic images (different techniques…NCT05710380·Chicago, Illinois and 1 other

PreviousPage 14 of 20Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma